The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
Glenmark will begin distribution in November 2025
Budesonide is indicated for mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in adults and children 8 years of age and olde
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
